金健米業(600127.SH):部分應收賬款壞賬準備轉回預計增加2021年度利潤239.52萬元
格隆匯12月7日丨金健米業(600127.SH)公佈,公司全資子公司樂米樂公司和營銷公司於近日分別收到了新一佳超市有限公司管理人支付的新一佳超市有限公司債權清償款人民幣2,005,083.25元和390,129.93元,合計人民幣2,395,213.18元。
現因公司已對上述應收賬款全額計提壞賬準備,根據會計準則等相關政策規定,對於本次收回的債權清償款人民幣2,395,213.18元作為轉回的壞賬準備計入本期損益。預計增加公司2021年度利潤2,395,213.18元,具體會計處理須以會計師年度審計確認後的結果為準,敬請廣大投資者注意投資風險。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.